The myth of schizophrenia as a progressive brain disease
- PMID: 23172002
- PMCID: PMC3796078
- DOI: 10.1093/schbul/sbs135
The myth of schizophrenia as a progressive brain disease
Abstract
Schizophrenia has historically been considered to be a deteriorating disease, a view reinforced by recent MRI findings of progressive brain tissue loss over the early years of illness. On the other hand, the notion that recovery from schizophrenia is possible is increasingly embraced by consumer and family groups. This review critically examines the evidence from longitudinal studies of (1) clinical outcomes, (2) MRI brain volumes, and (3) cognitive functioning. First, the evidence shows that although approximately 25% of people with schizophrenia have a poor long-term outcome, few of these show the incremental loss of function that is characteristic of neurodegenerative illnesses. Second, MRI studies demonstrate subtle developmental abnormalities at first onset of psychosis and then further decreases in brain tissue volumes; however, these latter decreases are explicable by the effects of antipsychotic medication, substance abuse, and other secondary factors. Third, while patients do show cognitive deficits compared with controls, cognitive functioning does not appear to deteriorate over time. The majority of people with schizophrenia have the potential to achieve long-term remission and functional recovery. The fact that some experience deterioration in functioning over time may reflect poor access, or adherence, to treatment, the effects of concurrent conditions, and social and financial impoverishment. Mental health professionals need to join with patients and their families in understanding that schizophrenia is not a malignant disease that inevitably deteriorates over time but rather one from which most people can achieve a substantial degree of recovery.
Keywords: MRI; cognition; outcome; prognosis; recovery; remission.
Similar articles
-
The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness.J Clin Psychiatry. 2014;75 Suppl 2:8-13. doi: 10.4088/JCP.13065su1.02. J Clin Psychiatry. 2014. PMID: 24919165 Review.
-
The early longitudinal course of cognitive deficits in schizophrenia.J Clin Psychiatry. 2014;75 Suppl 2(0 2):25-9. doi: 10.4088/JCP.13065.su1.06. J Clin Psychiatry. 2014. PMID: 24919168 Free PMC article. Review.
-
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.Schizophr Res. 2015 Aug;166(1-3):9-16. doi: 10.1016/j.schres.2015.04.040. Epub 2015 May 15. Schizophr Res. 2015. PMID: 25982811
-
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199. Arch Gen Psychiatry. 2011. PMID: 21300943 Free PMC article.
-
Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients.Psychol Med. 2014 Jun;44(8):1591-604. doi: 10.1017/S0033291713002365. Epub 2013 Sep 26. Psychol Med. 2014. PMID: 24067252
Cited by
-
The progression of disorder-specific brain pattern expression in schizophrenia over 9 years.NPJ Schizophr. 2021 Jun 14;7(1):32. doi: 10.1038/s41537-021-00157-0. NPJ Schizophr. 2021. PMID: 34127678 Free PMC article.
-
Positive Coping and Resilience as Mediators Between Negative Symptoms and Disability Among Patients With Schizophrenia.Front Psychiatry. 2019 Sep 10;10:641. doi: 10.3389/fpsyt.2019.00641. eCollection 2019. Front Psychiatry. 2019. PMID: 31551832 Free PMC article.
-
Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States.Front Psychiatry. 2021 Oct 26;12:695672. doi: 10.3389/fpsyt.2021.695672. eCollection 2021. Front Psychiatry. 2021. PMID: 34764891 Free PMC article.
-
Magnetic resonance advanced imaging analysis in adolescents: cortical thickness study to identify attenuated psychosis syndrome.Neuroradiology. 2023 Oct;65(10):1447-1458. doi: 10.1007/s00234-023-03200-2. Epub 2023 Aug 1. Neuroradiology. 2023. PMID: 37524967
-
Anosognosia in schizophrenia: hidden in plain sight.Innov Clin Neurosci. 2014 May;11(5-6):10-7. Innov Clin Neurosci. 2014. PMID: 25152841 Free PMC article.
References
-
- Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet. 2007;370:859–877 - PubMed
-
- Jablensky A. Living in a Kraepelinian world: Kraepelin’s impact on modern psychiatry. Hist Psychiatry. 2007;18:381–388 - PubMed
-
- Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry. 1999;46:729–739 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical